Rottapharm plans debut high yield bond as step towards IPO
Rottapharm Madaus, an Italian-German pharmaceutical company, is looking to raise €400m in its debut bond issue. The planned notes are senior unsecured, have a 2019 maturity and are callable after three years.
JP Morgan is global coordinator, Banca Imi and Mediobanca joint bookrunners.
A roadshow started in London on Monday and will finish on Thursday, after visiting Frankfurt, Paris, Amsterdam and Milan.With the proceeds of the Ba3/BB- rated notes and a new 100m bilateral loan facility, Rottapharm plans to repay ...